|Articles|August 5, 2016

Pharma Company Selects OmniComm Platform

OmniComm Systems announces the selection of its Trial One platform by a pharmaceutical company to automate its Phase I and BA/BA clinic.

OmniComm Systems announces the selection of its Trial One platform by a pharmaceutical company to automate its Phase I and BA/BE clinic. The company aims to standardize its processes, improve business intelligence, ensure compliance, and transform its overall business within its early phase research.
Read the full release here

Newsletter

Stay current in clinical research with Applied Clinical Trials, providing expert insights, regulatory updates, and practical strategies for successful clinical trial design and execution.